Glenmark Pharmaceuticals Ltd NSE  /  BSE

Pharmaceuticals, Mid Cap

15 Jan 2021 | 04:14 PM

512.10
-8.30 (-1.59%)

F&O

Level of activity in a company's derivative contracts can signal a lot about company's future and market expectations.

 15 Jan 21 | 12:00 AM


GLENMARK-FUTSTK-28Jan2021
GLENMARK-FUTSTK-28Jan2021

511.70 -11.20(-2.14%)

  • Volume(000)

    2,093

  • Lot size

    1,150

  • Open Interest(000)

    4,984

  • Change in OI

    -89,700